Exact Sciences Corporation
Clinical trials sponsored by Exact Sciences Corporation, explained in plain language.
-
New blood test aims to catch liver cancer earlier in At-Risk patients
Diagnosis OngoingThis study is testing a new blood test called Oncoguard Liver to see how well it detects liver cancer (hepatocellular carcinoma) in people at increased risk, such as those with cirrhosis or hepatitis B. About 3,000 participants will provide a blood sample and undergo imaging like…
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
150,000 people tracked to see if At-Home stool test can slash colon cancer deaths
Diagnosis OngoingThis study follows 150,000 adults in the U.S. who were prescribed the Cologuard stool test for colorectal cancer screening. Researchers want to see how many people get a follow-up colonoscopy after a positive result and how often cancer is found. The goal is to understand the rea…
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Blood test may spot hidden cancer DNA after surgery
Knowledge-focused OngoingThis study is testing a blood test that looks for tiny bits of cancer DNA in the blood after colorectal cancer surgery. The goal is to see if this test can predict whether the cancer will return. Over 1,000 people with stage II or III colorectal cancer will be followed for up to …
Sponsor: Exact Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC